OTTAWA (dpa-AFX) - Medical device maker Boston Scientific Corp. (BSX) said Monday that it has received CE Mark approval for use of the GUIDE DBS System, the world's first deep brain stimulation visualization system.
GUIDE DBS provides clinicians with 3D visualization information that simulates stimulation output, which may reduce programming time and enable more precise targeting of therapy. With GUIDE DBS, physicians are able to visualize the relative position of lead location and utilize stimulation field models within the brain.
The innovative GUIDE DBS technology, combined with the Vercise DBS System, was developed to provide the most advanced deep brain stimulation technology to neurologists, neurosurgeons and their patients.
GUIDE DBS and the Vercise DBS System are CE Marked for the treatment of Parkinson's disease. The Vercise DBS System was approved for sale in Europe in 2012.
In the U.S., the GUIDE DBS and Vercise DBS Systems are investigational and not available for sale.
GUIDE DBS is the first commercial product resulting from the Boston Scientific acquisition of Intelect Medical in 2011.
Copyright RTT News/dpa-AFX
Jetzt für 0€ handeln - auf Smartbroker.de